GeneCopoeia OncoSpot Cancer Cell Lines

Friday, 01 June, 2018 | Supplied by: United Bioresearch Products Pty Ltd


Cancer cell lines

GeneCopoeia offers premade cancer cell lines carrying diverse gene mutations commonly seen in tumour biomarkers, including EGFR, KRAS and BRAF in the MAPK pathway.

The mutant cells are engineered based on the HCT116 cancer cell line, in which mutations are integrated either homozygously or heterozygously using CRISPR technology. They can be used to enhance our understanding of cancer biology and the development of cancer therapies, either as cell line models for the study of metabolic and signalling pathways or as in vitro models for drug screening and toxicity studies.

The cell lines feature puromycin resistance for easy growth and maintenance. Mutations are available in both homozygous and heterozygous forms. Premade cell lines are available for next-day shipping; a custom cell line service is also available.

For more information: http://www.genecopoeia.com/product/cell-biology-product/cancer-mutant-cell-lines/.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Phase Genomics Hi-C proximity ligation kits

Phase Genomics applies Hi-C and other proximity-ligation methods to enable chromosome-scale...

Mercodia Total GIP Northern Lights (NL)-ELISA

Mercodia's Total GIP NL-ELISA provides a chemiluminescent method for the quantitative...

Merck Plug & Play Upstream Development Service

Merck has launched its Plug & Play Upstream Development Service to help emerging biotech and...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd